School of Medicine, China Medical University, Taichung 40447, Taiwan.
3D Printing Medical Research Center, China Medical University Hospital, Taichung 40447, Taiwan.
Int J Mol Sci. 2019 Feb 21;20(4):942. doi: 10.3390/ijms20040942.
Currently, clinically available orthopedic implants are extremely biocompatible but they lack specific biological characteristics that allow for further interaction with surrounding tissues. The extracellular matrix (ECM)-coated scaffolds have received considerable interest for bone regeneration due to their ability in upregulating regenerative cellular behaviors. This study delves into the designing and fabrication of three-dimensional (3D)-printed scaffolds that were made out of calcium silicate (CS), polycaprolactone (PCL), and decellularized ECM (dECM) from MG63 cells, generating a promising bone tissue engineering strategy that revolves around the concept of enhancing osteogenesis by creating an osteoinductive microenvironment with osteogenesis-promoting dECM. We cultured MG63 on scaffolds to obtain a dECM-coated CS/PCL scaffold and further studied the biological performance of the dECM hybrid scaffolds. The results indicated that the dECM-coated CS/PCL scaffolds exhibited excellent biocompatibility and effectively enhanced cellular adhesion, proliferation, and differentiation of human Wharton's Jelly mesenchymal stem cells by increasing the expression of osteogenic-related genes. They also presented anti-inflammatory characteristics by showing a decrease in the expression of tumor necrosis factor-alpha (TNF-α) and interleukin-1 (IL-1). Histological analysis of in vivo experiments presented excellent bone regenerative capabilities of the dECM-coated scaffold. Overall, our work presented a promising technique for producing bioscaffolds that can augment bone tissue regeneration in numerous aspects.
目前,临床可用的骨科植入物具有极高的生物相容性,但它们缺乏允许与周围组织进一步相互作用的特定生物特性。由于能够上调再生细胞行为,细胞外基质(ECM)涂层支架在骨再生方面受到了相当大的关注。本研究深入探讨了设计和制造三维(3D)打印支架的问题,这些支架由硅酸钙(CS)、聚己内酯(PCL)和来自 MG63 细胞的去细胞外基质(dECM)制成,生成了一种有前途的骨组织工程策略,其核心概念是通过创建具有成骨促进作用的 dECM 的诱导成骨微环境来增强成骨作用。我们在支架上培养 MG63,以获得 dECM 涂层的 CS/PCL 支架,并进一步研究了 dECM 杂化支架的生物学性能。结果表明,dECM 涂层的 CS/PCL 支架具有优异的生物相容性,并通过增加成骨相关基因的表达,有效增强了人脐带来源间充质干细胞的细胞黏附、增殖和分化。它们还通过降低肿瘤坏死因子-α(TNF-α)和白细胞介素-1(IL-1)的表达呈现出抗炎特性。体内实验的组织学分析显示 dECM 涂层支架具有出色的骨再生能力。总的来说,我们的工作提出了一种有前途的生产生物支架的技术,可在多个方面增强骨组织再生。